Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 3.112\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccc(N2C(=O)N(CC(=O)Nc3cc(F)ccc3C)C(=O)C2C)cc1
(b) FC(F)(F)c1ccnc(N2CCN(Cc3cnc(-c4ccccc4)[nH]3)CC2)c1
(c) O=C(NCC1COc2ccccc2O1)c1ccc(Cl)cc1
Answer: b. FC(F)(F)c1ccnc(N2CCN(Cc3cnc(-c4ccccc4)[nH]3)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
FC(F)(F)c1ccnc(N2CCN(Cc3cnc(-c4ccccc4)[nH]3)CC2)c1
FC(F)(F)c1ccnc(N2CCN(Cc3cnc(-c4ccccc4)[nH]3)CC2)c1
1-[(2-phenyl-1H-imidazol-5-yl)methyl]-4-[4-(trifluoromethyl)pyridin-2-yl]piperazine